Mannitol (Osmitrol, Resectisol)

Category:

  • Diuretic

Description:

  • Osmolar diuretic

Indications:

  • Reduction of intracranial pressure associated with cerebral edema

  • Reduction of intraocular pressure

  • Improve renal function in oliguric phase of acute renal failure

  • Promote urinary excretion of toxic substances

Contraindications:

  • Active intracranial bleeding

  • Anuria; severe pulmonary congestion or edema; severe dehydration  

Precautions:

  • Pregnancy category C

  • Monitor serum electrolytes, urine output  

Adverse Reactions (Side Effects):

  • CNS: confusion, dizziness, seizures, headache, rebound increased intracranial pressure

  • CV: angina-like chest pain, CHF, edema, hypertension, hypotension, tachycardia, thrombophlebitis

  • EENT: blurred vision, loss of hearing, nasal congestion

  • GU: osmotic necrosis, urinary retention

  • METAB: acidosis, dehydration, electrolyte loss, fluid and electrolyte imbalances

  • SKIN: skin necrosis, urticaria

  • MISC: chills, fever  

Dosage:

Administered intravenously

  • Adult: Oliguria prevention: 

    • IV 50-100 grams of 5%-25% solution

    • Oliguria treatment: 

      • IV 50-100 grams of 15%-20% solution

    • Intraocular pressure, intracranial pressure: 

      • IV 1.5-2 g/kg of 15%-25% solution over 30-60 minutes

    • Diuresis in drug intoxication: 

      • IV 5%-10% solution continuously up to 200 grams while maintaining urine output of 100-500 ml/hr

    • Urologic irrigation: 

      • Add contents of two 50ml vials of 25% mannitol to 900ml sterile water for injection and use as irrigation

  • Child: 

    • IV 0.5-1 g/kg initially,k then 0.25-0.5 g/kg every 4-6 hours for maintenance

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site